We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$31.6M
AUM Growth
+$859K
Cap. Flow
-$61.4K
Cap. Flow %
-0.19%
Top 10 Hldgs %
36.15%
Holding
38
New
–
Increased
–
Reduced
5
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$39.1K
2
AAPL icon
Apple
AAPL
+$8.94K
3
INTC icon
Intel
INTC
+$8.22K
4
UNH icon
UnitedHealth
UNH
+$3.93K
5
GE icon
GE Aerospace
GE
+$1.27K

Sector Composition

Rank Sector Weight
1 Healthcare 24.83%
2 Financials 22.65%
3 Technology 12.34%
4 Industrials 11.87%
5 Consumer Staples 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$1.34M 4.24%
57,764
-420
-0.7% -$8.94K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$1.23M 3.89%
11,760
– –
MKL icon
3
Markel Group
MKL
$23.3B
$1.23M 3.87%
1,870
– –
HON icon
4
Honeywell
HON
$77B
$1.18M 3.72%
14,084
– –
BAC icon
5
Bank of America
BAC
$435B
$1.17M 3.69%
75,996
– –
INTC icon
6
Intel
INTC
$455B
$1.11M 3.51%
35,967
-300
-0.8% -$8.22K
UNH icon
7
UnitedHealth
UNH
$376B
$1.08M 3.4%
13,160
-50
-0.4% -$3.93K
ELV icon
8
Elevance Health
ELV
$81.5B
$1.05M 3.33%
9,805
– –
JPM icon
9
JPMorgan Chase
JPM
$935B
$1.05M 3.31%
18,193
– –
QCOM icon
10
Qualcomm
QCOM
$155B
$1.01M 3.18%
12,710
– –
YUM icon
11
Yum! Brands
YUM
$41.8B
$996K 3.15%
17,068
– –
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.1T
$988K 3.12%
7,805
– –
TEVA icon
13
Teva Pharmaceuticals
TEVA
$40.8B
$978K 3.09%
18,660
– –
PFE icon
14
Pfizer
PFE
$143B
$961K 3.04%
34,143
-1,370
-4% -$39.1K
AON icon
15
Aon
AON
$76.5B
$955K 3.02%
10,600
– –
FLR icon
16
Fluor
FLR
$7.01B
$926K 2.93%
12,045
– –
PG icon
17
Procter & Gamble
PG
$336B
$926K 2.93%
11,786
– –
DEO icon
18
Diageo
DEO
$49B
$896K 2.83%
7,039
– –
EMR icon
19
Emerson Electric
EMR
$83.9B
$895K 2.83%
13,480
– –
KMB icon
20
Kimberly-Clark
KMB
$36.3B
$854K 2.7%
8,008
– –
CB
21
DELISTED
CHUBB CORPORATION
CB
$854K 2.7%
9,270
– –
CVX icon
22
Chevron
CVX
$392B
$849K 2.68%
6,505
– –
MRK icon
23
Merck
MRK
$322B
$810K 2.56%
14,682
– –
PEG icon
24
Public Service Enterprise Group
PEG
$38.2B
$794K 2.51%
19,455
– –
GE icon
25
GE Aerospace
GE
$374B
$759K 2.4%
6,028
-10
-0.2% -$1.27K
1
2

Similar funds

PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
AVA
Accel VIII Associates Palo Alto, California $65.1M AUM
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return

Needelman Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Needelman Asset Management held 38 positions worth $31.6M, up 2.8% from $30.8M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 0%. Needelman Asset Management opened no new positions and made no exits, leaving the 38-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

  • Needelman Asset Management's biggest Q2 2014 reduction was Pfizer, cutting an estimated $39.1K.
  • Needelman Asset Management's ten largest holdings make up 36% of its $31.6M portfolio in Q2 2014.
  • Needelman Asset Management opened 0 new positions and closed 0 in Q2 2014.
  • Needelman Asset Management's portfolio value rose 2.8% quarter-over-quarter to $31.6M.

Based on Needelman Asset Management's 13F filing for Q2 2014, filed 1 Jul 2014.